This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Share on Pinterest The FDA has approved vonoprazan (Voquezna), a new daily treatment for heartburn associated with GERD in adults. andreswd/Getty Images The FDA approved vonoprazan (Voquezna) as a ...

Gastroesophageal reflux disease (GERD), already one of the most common gastrointestinal conditions, is increasing in prevalence, yet it remains a difficult disease to diagnose. In North America, ...

A UK-wide research team, led by the University of Oxford's Nuffield Department of Surgical Sciences, has launched a major international study to improve surgical treatment for people suffering from ...